CHINA TIANRUI (01252) completes the placement and subscription matters.
China Tairui Cement (01252) announced that the subscription and subscription matters will be announced on January 3, 2025 and 2...
CHINA TIANRUI (01252) announces that the allocation and subscription matters were completed on January 3, 2025 and January 7, 2025, respectively.
All allocation conditions have been met and the allocation was completed on January 3, 2025. A total of 145 million shares were successfully allocated at a price of HK$0.33 per share to no fewer than six independent placing agents or their representatives selected and facilitated by the placing agent.
Furthermore, all conditions for the subscription matters have been met, and the subscription was completed on January 7, 2025. The seller subscribed to a total of 145 million shares (equivalent to the number of shares successfully allocated under the allocation matters), with a net subscription price of approximately HK$0.324 per share after deducting relevant costs, professional fees, and expenses. The subscription shares represent approximately 4.70% of the company's enlarged issued share capital after the subscription matters.
Related Articles
HK Stock Market Move | Zhejiang Sanhua Intelligent Controls (02050) gained more than 4% during trading hours, with expected annual net profit growth of 25%-50%. Siasun Robot & Automation business is expected to make breakthrough progress.

Sinolink: Initiate coverage on SIMCERE PHARMA (02096) with a "buy" rating and a target price of HK$20.16.

HK Stock Market Move | Policy support for the development of brain-machine interfaces. HEARTCARE-B (06609) rose more than 12%. BRAINAURORA-B (06681) rose nearly 8%.
HK Stock Market Move | Zhejiang Sanhua Intelligent Controls (02050) gained more than 4% during trading hours, with expected annual net profit growth of 25%-50%. Siasun Robot & Automation business is expected to make breakthrough progress.
Sinolink: Initiate coverage on SIMCERE PHARMA (02096) with a "buy" rating and a target price of HK$20.16.

HK Stock Market Move | Policy support for the development of brain-machine interfaces. HEARTCARE-B (06609) rose more than 12%. BRAINAURORA-B (06681) rose nearly 8%.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


